Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof

Details for Australian Patent Application No. 2009335398 (hide)

Owner Thrombologic ApS

Inventors Johansson, Par

Agent FB Rice

Pub. Number AU-A-2009335398

PCT Pub. Number WO2010/075861

Priority 61/161,487 19.03.09 US; PA 2008 01844 30.12.08 DK

Filing date 30 December 2009

Wipo publication date 8 July 2010

International Classifications

A61K 31/557 (2006.01) - Eicosanoids, e.g. leukotrienes

A61K 31/727 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

21 July 2011 PCT application entered the National Phase

  PCT publication WO2010/075861 Priority application(s): WO2010/075861

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009335405-Use of an APL peptide for the treatment of inflammatory bowel disease and type 1 diabetes

2009335397-Barley with reduced lipoxygenase activity